Samsung Biologics earnings (net income)
Samsung Biologics (207940) earned a net income of $1.34 B in fiscal year 2025, +64.7% compared with the year before. Net profit margin: 39.2% of revenue.
Earnings 2025$1.34 B
Change+64.7%
World rank#399
Market cap$50.11 B
Net income by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $1.34 B | +64.7% |
| 2024 | $813.93 M | +26.3% |
| 2023 | $644.41 M | +7.47% |
| 2022 | $599.60 M | — |
Converted to US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.